Skip to content

Opko Health OPK Book value per share

Book value per share at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$65.77+7.3%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$4.67+4.1%
HRO
HarrowHROW
$0.77-51.1%
Precigen logo
PrecigenPGEN
$0.06+219%
Immunome logo
ImmunomeIMNM
$5.20+34.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$2.35-257%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Calculated from Opko Health’s reported figures.

Based on the most recent quarter.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's book value per share?
Opko Health (OPK) reported book value per share of $1.59 in Q1 2026.
How has Opko Health's book value per share changed year-over-year?
Opko Health's book value per share decreased by 18.7% year-over-year, from $1.95 to $1.59.
What is the long-term trend for Opko Health's book value per share?
Over 5 years (2020 to 2025), Opko Health's book value per share has grown at a -8.3% compound annual growth rate (CAGR), from $2.61 to $1.69.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.